Cardioprotective Strategies After Ischemia-Reperfusion Injury

被引:5
|
作者
Zhang, Honghong [1 ]
Hu, Huilin [1 ]
Zhai, Changlin [1 ]
Jing, Lele [1 ]
Tian, Hongen [1 ]
机构
[1] Jiaxing Univ, Affiliated Hosp, Hosp Jiaxing 1, Dept Cardiol, 1882 Zhonghuan South Rd, Jiaxing 314000, Zhejiang, Peoples R China
关键词
ACUTE MYOCARDIAL-INFARCTION; KINASE-C-ALPHA; NF-KAPPA-B; THERAPEUTIC HYPOTHERMIA; QUALITY-CONTROL; HYPEROXEMIC REPERFUSION; HYPERBARIC OXYGENATION; HEART-FAILURE; IMPELLA; 2.5; SUMOYLATION;
D O I
10.1007/s40256-023-00614-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acute myocardial infarction (AMI) is associated with high morbidity and mortality worldwide. Although early reperfusion is the most effective strategy to salvage ischemic myocardium, reperfusion injury can develop with the restoration of blood flow. Therefore, it is important to identify protection mechanisms and strategies for the heart after myocardial infarction. Recent studies have shown that multiple intracellular molecules and signaling pathways are involved in cardioprotection. Meanwhile, device-based cardioprotective modalities such as cardiac left ventricular unloading, hypothermia, coronary sinus intervention, supersaturated oxygen (SSO2), and remote ischemic conditioning (RIC) have become important areas of research. Herein, we review the molecular mechanisms of cardioprotection and cardioprotective modalities after ischemia-reperfusion injury (IRI) to identify potential approaches to reduce mortality and improve prognosis in patients with AMI.
引用
收藏
页码:5 / 18
页数:14
相关论文
共 50 条
  • [11] Cardioprotective effects of Amentoflavone by suppression of apoptosis and inflammation on an in vitro and vivo model of myocardial ischemia-reperfusion injury
    Li, Wei-wei
    Dan Li
    Yao Qin
    Sun, Cheng-xin
    Wang, Yong-ling
    Lei Gao
    Lang Ling-Hu
    Feng Zhang
    Wen Cai
    Lei Zhu
    Gang Wang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 101
  • [12] Upregulation of Small Ubiquitin-Like Modifier 2 and Protein SUMOylation as a Cardioprotective Mechanism Against Myocardial Ischemia-Reperfusion Injury
    Zhao, Wei
    Zhao, Jia
    Zhang, Xiuying
    Fan, Ni
    Rong, Jianhui
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [13] Cardioprotective Effects of Exogenous and Endogenous Hydrocortisone in the Rabbit Model of Ischemia-Reperfusion
    Davarian, Ali
    Khori, Vahid
    Nayebpour, Mohsen
    INTERNATIONAL JOURNAL OF MORPHOLOGY, 2010, 28 (03): : 653 - 658
  • [14] Nanotheranostics for the Management of Hepatic Ischemia-Reperfusion Injury
    Guan, Yu
    Yao, Weifeng
    Yi, Ke
    Zheng, Chunxiong
    Lv, Shixian
    Tao, Yu
    Hei, Ziqing
    Li, Mingqiang
    SMALL, 2021, 17 (23)
  • [15] The Effect of Silymarin on Mesenteric Ischemia-Reperfusion Injury
    Demir, M.
    Amanvermez, R.
    Polat, A. Kamali
    Karabicak, I.
    Cinar, H.
    Kesicioglu, T.
    Polat, C.
    MEDICAL PRINCIPLES AND PRACTICE, 2014, 23 (02) : 140 - 144
  • [16] A win in protection against ischemia-reperfusion injury?
    Fricke, Tyson A.
    Konstantinov, Igor E.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 157 (02) : 504 - 505
  • [17] Regulated necrosis in kidney ischemia-reperfusion injury
    Pefanis, Aspasia
    Ierino, Francesco L.
    Murphy, James M.
    Cowan, Peter J.
    KIDNEY INTERNATIONAL, 2019, 96 (02) : 291 - 301
  • [18] Mitochondria as a therapeutic target for cardiac ischemia-reperfusion injury (Review)
    Marin, Wenwen
    Marin, Dennis
    Ao, Xiang
    Liu, Ying
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2021, 47 (02) : 485 - 499
  • [19] The influence of lung ischemia-reperfusion injury on myocardium
    Shi, Meng
    Huang, Jiechun
    Pang, Liewen
    Sun, Xiaotian
    Chu, Xianglin
    Jang, Rongrong
    Xu, Xiaolin
    Wang, Yiqing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 7 (12): : 4780 - 4786
  • [20] Trimetazidine ameliorates myocardial ischemia-reperfusion injury
    He, Chuanbo
    Cao, Shujun
    Tong, Zichuan
    Wang, Wenbin
    Zhang, Yin
    Guo, Changlei
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 31 (04) : 1691 - 1696